An umbrella review of meta-analysis to understand the effect of coffee consumption and the relationship between stroke, cardiovascular heart disease, and dementia among its global users
Ein Umbrella-Review von Metaanalysen zum Effekt des Kaffeekonsums und zum Zusammenhang mit Schlaganfall, koronarer Herzkrankheit und Demenz bei globalen Nutzer:innen
Journal of Family Medicine and Primary Care · 2024-11 · 13 (11) · 4783-4796
DOI: 10.4103/jfmpc.jfmpc_654_24 ↗Auf einen Blick
Das Umbrella-Review fasste Metaanalysen zu Kaffee und Schlaganfall, KHK und Demenz zusammen. Bis zu 4 Tassen Kaffee täglich waren mit geringerem Schlaganfallrisiko verbunden; das KHK-Risiko war erhöht.
Fragestellung
Wie hängt Kaffeekonsum mit dem Risiko für Schlaganfall, koronare Herzkrankheit und Demenz zusammen?
Methode
Umbrella-Review von Metaanalysen; Suche in PubMed mit Metaanalyse-Filter; Untersuchungen bis Oktober 2023.
Ergebnisse
11 Metaanalysen aus 457052 Publikationen mit 11,96 Millionen Personen. Bis zu 4 Tassen/Tag: RR 0,88 (95 % KI 0,84–0,92; I2 13 %) für Schlaganfall. KHK: RR 1,19 (95 % KI 0,99–1,38; I2 84 %). Demenz: RR 0,90 (95 % KI 0,82–0,97; I2 46 %).
Einschränkungen
Nicht-englischsprachige Beobachtungsstudien, Fallberichte und Tierstudien ausgeschlossen.
Schlussfolgerung der Autor:innen
Die Autor:innen berichten, dass 4 Tassen Kaffee pro Tag das Schlaganfallrisiko senken können; hoher Kaffeekonsum war mit einem höheren KHK-Risiko verbunden.
Kernaussagen
- Bis zu 4 Tassen/Tag: niedrigeres Schlaganfallrisiko
- KHK-Risiko bei Kaffeetrinker:innen höher
- Demenzrisiko bei Koffein-Nutzer:innen niedriger
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Family Medicine and Primary Care, online erschienen am 18.11.2024. Verfasst von Harmeet Gill und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, HopeHealth, Florence, SC, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Demenz, Schlaganfall
Abstract (Originalsprache)
A BSTRACT Coffee has long been popular worldwide. The rise in lifestyle-related diseases such as cardiovascular disease, diabetes, stroke, dementia, and others has motivated coffee usage and illness prevalence studies. Some studies show coffee consumers are at risk for such diseases, whereas others show its active components protect them. Policymakers and the public need a comprehensive umbrella review to make healthy choices and enjoy coffee. Coffee consumption and stroke, CHD, and dementia outcomes have been distinguished using the PICO search strategy in PubMed with a filter for meta-analysis. We included 10 years of investigations until October 2023. MeSH terms “coffee intake,” “stroke, dementia,” and “transient ischemic attack,” comparing stroke risk with coffee consumption were used. The study excluded case reports and non-human, non-English observational research. The stroke risk of coffee was examined using RevMan software. Coffee consumption’s stroke risk ratio (RR), 95% CI, and I2 were estimated. Forest plots with P values ≤ 0.05 are significant. The umbrella review includes 11 meta-analyses from 457052 papers, totalling 11.96 million individuals. Drinking up to 4 cups of coffee daily reduced stroke risk by 12% compared with not drinking any coffee (0.88 (CI of 0.84-0.92, I2 of 13%, P < 0.00001)). Coffee drinkers had a 1.19 risk ratio for cardiovascular diseases compared to non-coffee drinkers (CI: 0.99–1.38, I2 = 84%, P < 0.00001). The dementia risk ratio for caffeine users was 0.90 (95% CI: 0.82-0.97, I2 = 46%, P < 0.00001) compared with non-consumers. Our analysis covering 5.42 million individuals found that 4 cups of coffee consumed a day reduced stroke risk by 12%. Coffee may reduce ischemic and haemorrhagic strokes by preserving endothelium and antioxidants. Coffee may lessen dementia risk, according to our study’s 0.94 pooled risk ratio after sensitivity analysis. Heavy coffee drinkers had a greater CHD risk, as per our findings. Heavy coffee drinkers were more at risk.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, HopeHealth, Florence, SC, USA.
- Department of Medicine, MBBS Medical Student, GMERS Medical College Gotri, Vadodara, Gujarat, India.
- Department of Health and Family Welfare, Primary Health Center, Navsari, Gujarat, India.
- Department of Anatomy, Shantabaa Medical College, Amreli, Gujarat, India.
- Department of Preventive and Social Medicine, SNMMCH, Dhanbad, Jharkhand, India.
- Department of Geriatrics, Hackensack University Medical Center, Hackensack, New Jersey, USA.
Zitieren
APA
Gill, H., Patel, N., Naik, N., Vala, L., Rana, R. K., Jain, S., Sirekulam, V., Jain, S. M., Khan, T., Kinthada, S., Patel, R. B., Nanjundappa, A., Siripuram, C., & Patel, U. (2024). An umbrella review of meta-analysis to understand the effect of coffee consumption and the relationship between stroke, cardiovascular heart disease, and dementia among its global users. Journal of Family Medicine and Primary Care, 13(11), 4783-4796. https://doi.org/10.4103/jfmpc.jfmpc_654_24
Vancouver
Gill H, Patel N, Naik N, Vala L, Rana RK, Jain S, et al. An umbrella review of meta-analysis to understand the effect of coffee consumption and the relationship between stroke, cardiovascular heart disease, and dementia among its global users. Journal of Family Medicine and Primary Care. 2024;13(11):4783-4796. doi:10.4103/jfmpc.jfmpc_654_24
BibTeX
@article{Gill2024,
author = {Gill, Harmeet and Patel, Neel and Naik, Nishthaben and Vala, Lovekumar and Rana, Rishabh K and Jain, Sakshi and Sirekulam, Vaishnavi and Jain, Shika M and Khan, Tanzina and Kinthada, Sudharani and Patel, Rashi B and Nanjundappa, Athmananda and Siripuram, Chandu and Patel, Urvish},
title = {An umbrella review of meta-analysis to understand the effect of coffee consumption and the relationship between stroke, cardiovascular heart disease, and dementia among its global users},
journal = {Journal of Family Medicine and Primary Care},
year = {2024},
volume = {13},
number = {11},
pages = {4783--4796},
doi = {10.4103/jfmpc.jfmpc_654_24}
}
EUVIMED